Analyst Recommendations

UBS analyst issues BUY recommendation for BKNG on February 22, 2024 09:46AM ET. The previous analyst recommendation was Buy.BKNG was trading at $3836.17 at issue of the analyst...

February 22, 2024   BKNG -1.55%

Stifel Nicolaus analyst issues UNDERPERFORM recommendation for UFPI on February 22, 2024 09:00AM ET. The previous analyst recommendation was Underperform.UFPI was trading at $110.11 at issue of the...

February 22, 2024   UFPI -1.89%

Wedbush analyst issues BUY recommendation for UFPI on February 22, 2024 09:00AM ET. The previous analyst recommendation was Buy.UFPI was trading at $110.11 at issue of the analyst...

February 22, 2024   UFPI -1.89%

Leerink Partners analyst issues UNDERPERFORM recommendation for UTHR on February 22, 2024 09:00AM ET. The previous analyst recommendation was Underperform.UTHR was trading at $219.18 at issue of the...

February 22, 2024   UTHR -0.19%

Wedbush analyst issues BUY recommendation for UTHR on February 22, 2024 09:00AM ET. The previous analyst recommendation was Buy.UTHR was trading at $219.18 at issue of the analyst...

February 22, 2024   UTHR -0.19%

Barclays analyst issues OVERWEIGHT recommendation for NEE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.NEE was trading at $57.1 at issue of the analyst...

February 22, 2024   NEE 0.86%

Seaport Global analyst issues SELL recommendation for NEE on February 22, 2024 08:42AM ET. NEE was trading at $57.1 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   NEE 0.86%

Barclays analyst issues OVERWEIGHT recommendation for SRE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.SRE was trading at $71.96 at issue of the analyst...

February 22, 2024   SRE 1.05%

Oppenheimer analyst issues OUTPERFORM recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Neutral.MRNA was trading at $87.59 at issue of the analyst...

February 22, 2024   MRNA -3.69%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Equal-Weight.MRNA was trading at $87.59 at issue of the...

February 22, 2024   MRNA -3.69%